Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms of vascular endothelial growth factor on prognosis in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization treatment.

Genetics and molecular research : GMR - 31 Oct 2014

Song J, Wang L Z, Li X, Jiang T P, An T Z, Xu M, Wu X P, Zhou S

Abstract excerpt

We conducted a cohort study to investigate the prognostic significance of vascular endothelial growth factor (VEGF) polymorphisms in hepatocellular carcinoma (HCC) patients after transcatheter arterial chemoembolization (TACE). In total, 156 patients with histologically confirmed HCC within 2 months were collected from January 2007 to January 2008. The genotypes of VEGF-2578C/A, -1154G/A, -634C/G, and -1498T/C...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Liver Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Multivariate Analysis

Share to Outcome Assessment, Health Care

Share to Proportional Hazards Models

Share to Survival Analysis

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 25366785
DOI: 10.4238/2014.October.31.9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms of vascular endothelial growth factor on prognosis in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization treatment.PMID 25366785Read ↗

Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population.Semantic proximity Read ↗

Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients.Semantic proximity Read ↗

Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.Semantic proximity Read ↗

Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients.Semantic proximity Read ↗

Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis.Semantic proximity Read ↗

Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.Semantic proximity Read ↗

Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.Semantic proximity Read ↗

Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.Semantic proximity Read ↗

Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.Semantic proximity Read ↗

Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.Semantic proximity Read ↗

Vascular endothelial growth factor gene polymorphisms in thyroid cancer.Semantic proximity Read ↗

Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.